Key result
Initial TEVAR plus OMT linked to ~10-fold higher odds of whole-aorta remodeling versus OMT alone.
Why the study?
The study was conducted to evaluate aortic remodeling and mid-term clinical outcomes in patients with acute type B aortic dissection according to initial management strategy.
Does TEVAR plus OMT improve aortic remodeling compared to OMT alone in patients with acute type B aortic dissection?
Cohort (n=61)
No
Does TEVAR plus OMT improve aortic remodeling compared to OMT alone in patients with acute type B aortic dissection?
Odds Ratio: 9.92 (95% CI 1.91–51.55)
Absolute Event Rate: 43% vs 6%
p-value: p=.006
In patients with acute type B aortic dissection, initial TEVAR combined with optimal medical therapy is associated with significantly better aortic remodeling compared to medical therapy alone.
TEVAR for complicated acute TBAD was associated with better remodeling; this Level 3 cohort leaves open whether it improves survival or reduces reinterventions.
Objective To evaluate aortic remodeling and mid-term clinical outcomes in patients with acute type B aortic dissection (TBAD) according to initial management strategy. Methods This retrospective single-center cohort study included consecutive patients with acute TBAD (symptom duration ≤14 days) treated between 2003 and 2021. Patients were grouped by management strategy (optimal medical therapy [OMT], n=47; thoracic endovascular aortic repair [TEVAR] plus OMT, n=14). Computed tomography angiography was used to measure aortic diameters at four predefined anatomical levels. Primary endpoints were whole-aorta remodeling and segmental (proximal descending thoracic) remodeling on the last follow-up computed tomography. Secondary endpoints were all-cause mortality, any aortic reintervention, and freedom from first reintervention. Predictors of remodeling were assessed using multivariable logistic regression, and survival analyses were performed using Kaplan-Meier methods. No formal sample size calculation was performed owing to the retrospective design; regression models were adjusted for prespecified covariates. Results Whole-aorta remodeling occurred in 9 of 61 patients (15%) (TEVAR 6/14 [43%] vs OMT 3/47 [6%]), and segmental remodeling in 19 of 61 (31%) (TEVAR 11/14 [79%] vs OMT 8/47 [17%]). Initial TEVAR showed an independent association with whole-aorta remodeling (odds ratio [OR], 9.92; 95% confidence interval [CI], 1.91-51.55; P = .006) and segmental remodeling (OR, 31.92; 95% CI, 4.99-204.09; P < .001). A false lumen diameter >20 mm was associated with reduced odds of segmental remodeling (OR, 0.20; 95% CI, 0.04-0.92; P = .038). During follow-up, five of 61 patients (8%) died, and 33 of 61 (54%) underwent at least one aortic reintervention. In unadjusted analyses, overall survival and freedom from first reintervention did not differ significantly between initial management groups (log-rank P = .41 and P = .43). Conclusions In this real-world cohort of acute TBAD, primary TEVAR performed for acute complicated presentations was associated with more favorable aortic remodeling, particularly within the treated thoracic segment. Because treatment allocation was indication-driven, comparisons of survival and freedom from reintervention between groups are descriptive only. The high rate of subsequent aortic procedures underscores the need for lifelong imaging surveillance and often staged repair.
No takes yet. Share an insight, caveat, or question.
Hamouda et al. (2026) conducted a cohort in Acute type B aortic dissection (n=61). Thoracic endovascular aortic repair (TEVAR) plus optimal medical therapy vs. Optimal medical therapy (OMT) alone was evaluated on Whole-aorta remodeling (OR 9.92, 95% CI 1.91-51.55, p=.006). Initial TEVAR plus optimal medical therapy was associated with significantly higher odds of whole-aorta remodeling compared to medical therapy alone (OR 9.92; 95% CI 1.91-51.55; P=.006).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: